HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2,2,5,7,8-pentamethyl-6-hydroxychromane

inhibits vascular smooth muscle cell proliferation; structure in first source

Also Known As:

PMC pentamethylhydroxychromane

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - 2,2,5,7,8-pentamethyl-6-hydroxychromane: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - 2,2,5,7,8-pentamethyl-6-hydroxychromane: 1

Experts

1.	Kagan, V E: 1 article (03/2003)
2.	Kisin, E R: 1 article (03/2003)
3.	Kuzmenko, A I: 1 article (03/2003)
4.	Li, R: 1 article (03/2003)
5.	Martin, I: 1 article (03/2003)
6.	Quinn, P J: 1 article (03/2003)
7.	Shvedova, A A: 1 article (03/2003)
8.	Tyurin, V A: 1 article (03/2003)
9.	Tyurina, Y Y: 1 article (03/2003)
10.	Yalowich, J C: 1 article (03/2003)

Related Diseases

1.	Leukemia 03/17/2003 - "The goal of this work was to determine whether generation and recycling of MPO-catalyzed phenoxyl radicals of a vitamin E homologue, 2,2,5,7,8-pentamethyl-6-hydroxychromane (PMC), by physiologically relevant intracellular reductants such as ascorbate/lipoate could be demonstrated in intact MPO-rich human leukemia HL-60 cells. "

Related Drugs and Biologics

1.	Reducing Agents
2.	Vitamin E